Acula Technology Corp.

Acula Technology Corp. specializes in colour image display units, specifically LCD screens designed for medical imaging. Their most common products are 21.3-inch displays with resolutions of 5MP (UMD5-21B01) and 3MP (UMD3-21B01, also marketed as MD3-21B01). These devices are intended to interface with medical imaging systems, such as their own LUMIN series, to enhance diagnostic workflows by providing high-quality visual output.

Acula Technology Corp. is based in the United States, which means its medical devices fall under U.S. FDA regulations. Since the company’s products are Class II devices, they are subject to the FDA’s 510(k) premarket notification process and must comply with the Unique Device Identification (UDI) system to ensure traceability and post-market surveillance. The U.S. regulatory framework applies directly to these devices due to the company’s location.

Acula Technology Corp.’s devices are included in the FDA’s 510(k) registry and the FDA’s UDI database. Listing in these registries confirms that the devices have undergone the required 510(k) clearance process and are assigned a UDI, which is mandatory for Class II devices in the U.S. to support tracking and compliance. These registries are publicly accessible and provide transparency on authorised devices.

Acula Technology Corp.’s colour image display units are classified as Class II medical devices under U.S. regulations. This classification is determined by the risk posed by the device—while not invasive or life-supporting, these displays play a critical role in medical imaging by ensuring accurate visual representation of diagnostic data. Class II devices require special controls (like 510(k) clearance) to mitigate risks, such as ensuring display accuracy and compatibility with imaging systems, without needing the stricter oversight of Class III devices.